{
    "2018-04-11": [
        [
            {
                "time": "2018-04-12",
                "original_text": "J&J, Imerys unit must pay $117 million in New Jersey asbestos cancer case",
                "features": {
                    "keywords": [
                        "J&J",
                        "Imerys",
                        "asbestos",
                        "cancer",
                        "case"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-11",
                "original_text": "Novartis’s Valuation and Analysts’ Recommendations on April 11",
                "features": {
                    "keywords": [
                        "Novartis",
                        "valuation",
                        "analysts",
                        "recommendations"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-12",
                "original_text": "Asbestos in Talc Products Verdict Means J&J, Imerys Owe Millions",
                "features": {
                    "keywords": [
                        "asbestos",
                        "talc",
                        "products",
                        "verdict",
                        "J&J",
                        "Imerys"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-12",
                "original_text": "J&J, Imerys must pay $80 mln punitive damages in case linking cancer to asbestos in talc",
                "features": {
                    "keywords": [
                        "J&J",
                        "Imerys",
                        "punitive",
                        "damages",
                        "cancer",
                        "asbestos",
                        "talc"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-12",
                "original_text": "Novartis’s Stock Performance following the AveXis Agreement",
                "features": {
                    "keywords": [
                        "Novartis",
                        "stock",
                        "performance",
                        "AveXis",
                        "agreement"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-12",
                "original_text": "Karyopharm's Myeloma Candidate Gets Fast Track Designation",
                "features": {
                    "keywords": [
                        "Karyopharm",
                        "myeloma",
                        "candidate",
                        "fast",
                        "track",
                        "designation"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-12",
                "original_text": "Dow Analyst Moves: JNJ",
                "features": {
                    "keywords": [
                        "Dow",
                        "analyst",
                        "moves",
                        "JNJ"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-12",
                "original_text": "4 Blue-Chip Stocks to Buy Ahead of Eye-Popping Earnings",
                "features": {
                    "keywords": [
                        "blue-chip",
                        "stocks",
                        "buy",
                        "earnings"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-12",
                "original_text": "Alkermes Has Some Decisions to Make",
                "features": {
                    "keywords": [
                        "Alkermes",
                        "decisions"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-12",
                "original_text": "Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for April 12, 2018",
                "features": {
                    "keywords": [
                        "Abbott",
                        "Laboratories",
                        "ABT",
                        "ex-dividend",
                        "date"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-12",
                "original_text": "How GlaxoSmithKline Stock Performed in 1Q18",
                "features": {
                    "keywords": [
                        "GlaxoSmithKline",
                        "stock",
                        "performed",
                        "1Q18"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-12",
                "original_text": "Healthcare: Cancer breakthrough leads China’s biotech boom",
                "features": {
                    "keywords": [
                        "healthcare",
                        "cancer",
                        "breakthrough",
                        "China",
                        "biotech",
                        "boom"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}